Modeling the population-level impact of a third dose of MMR vaccine on a mumps outbreak at the University of Iowa.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
22 Oct 2024
Historique:
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 14 10 2024
Statut: ppublish

Résumé

Mumps outbreaks among fully vaccinated young adults have raised questions about potential waning of immunity over time and need for a third dose of the measles, mumps, rubella (MMR) vaccine. However, there are currently limited data on real-life effectiveness of the third-dose MMR vaccine in preventing mumps. Here, we used a deterministic compartmental model to infer the effectiveness of the third-dose MMR vaccine in preventing mumps cases by analyzing the mumps outbreak that occurred at the University of Iowa between August 24, 2015, and May 13, 2016. The modeling approach further allowed us to evaluate the population-level impact of vaccination by different timing in relation to the start of the outbreak and varied coverage levels, and to account for potential sources of bias in estimating vaccine effectiveness. We found large uncertainty in vaccine effectiveness estimates; however, our models showed that early introduction of a third dose of MMR vaccine during a mumps outbreak can be effective in preventing transmission. School holidays, such as the winter break, likely played important roles in preventing mumps transmission.

Identifiants

pubmed: 39401354
doi: 10.1073/pnas.2403808121
doi:

Substances chimiques

Measles-Mumps-Rubella Vaccine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2403808121

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Sang Woo Park (SW)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544.

Tomi Lawal (T)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544.

Mona Marin (M)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329.

Mariel A Marlow (MA)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329.

Bryan T Grenfell (BT)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544.

Nina B Masters (NB)

Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH